Choice Genetics is a global swine genetics company powered by Groupe Grimaud, the second largest multi-species animal genetics company in the world. Choice Genetics is committed to cutting edge, long-term investment in research and development advancement to address current and future industry demands. Choice Genetics operates on four continents to support pork producers seeking the highest in efficiency, performance and value. We have subsidiaries in Brazil, Canada, China, France, Germany, Poland, USA and Vietnam. Our breeding stock is marketed in more than 25 countries. Amongst the frontline products are the CG32 and NAÏMA parent gilts and the EBX and P88 terminal sires. Leading Innovation. Delivering Value. Choice Genetics employs value-driven innovations that emphasize unique phenotypic traits to increase the accuracy of EBV's, bringing to market superior products. Our dedication to a unique innovation platform drives genetic advancement in commercial pig total value at a rate faster than competitors.